AGP Picks
View all

World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on July 30, 2026

Celestial Seasonings® Expands Anytime Wellness Tea Line with Three New Functional Blends
Applied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™
CAMRT-AB urges workforce planning as Alberta expands self-referral for diagnostic imaging
AscellaHealth Delivers Mid-Year Specialty Pharmacy Outlook to Help Payers Navigate Pipeline Innovation, Cost and Benefit Strategy
Parker University Celebrates 75 Years of Parker Seminars with Landmark Dallas Homecoming Event
Verizon inicia la temporada de la NFL con NFL Sunday Ticket de YouTube, por nuestra cuenta
Airia Named a Representative Vendor in Gartner's Competitive Landscape: AI Governance Platforms Report
EasyVista Included in the 2026 Gartner® Magic Quadrant™ for IT Service Management Platforms & Forrester Wave: Conversational AI Platforms for Employee Services
Press Release: Sanofi’s half-year financial report for 2026
Communiqué de presse : Rapport financier semestriel 2026 de Sanofi
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
Decent Holding Advances AI-Powered Health Data Infrastructure Alongside Community Healthcare Network Expansion
Planet Fitness Franchise Groups Raise More Than $72,000 to Support the Lifesaving Mission of St. Jude Children’s Research Hospital
Marquee Raises $6.5 Million to Scale AI Decision Layer Across Global Sports
Jameson Irish Whiskey Joins the National Football League (NFL) as Official Spirits Sponsor, Expanding Its Commitment to Football Fan Culture Globally
New Healthy Moms, Healthy Babies America Poll Finds Broad Bipartisan Consensus: Americans Want More Action for Moms and Babies
Nerdio Recognized as a Major Player in the 2026 IDC MarketScapes for Worldwide Desktop as a Service and Virtual Client Computing
Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma
IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.